Hybridoma Development Studies and Antibody Production

SOL #: HT942525R0009Solicitation

Overview

Buyer

DEPT OF DEFENSE

Defense Health Agency (Dha)

ARMY MED RES ACQ ACTIVITY

FORT DETRICK, MD, 21702, United States

Place of Performance

Place of performance not available

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

Drugs And Biologicals (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/0f51c9c505eb4c2ab6050d0081137cc5/view

Timeline

Posted

Nov 26, 2024

Last Updated

Dec 19, 2024

Submission Deadline

Dec 23, 2024, 5:00 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

This is combined synopsis/solicitation for severable, non-personal service(s) contract to provide hybridoma development studies and antibody production for the Division of Virology at the USAMRIID, who conducts research in molecular virology, cell biology, immunology, viral virulence factor determination, and viral strain diversity characterization.